Latest Blogs
-
The number of new COVID cases continues to drop in Indiana
-
Developer plans new retail center on Michigan Road in Carmel
-
Bill would require nursing homes to allow ‘compassionate care’ visits during pandemic
-
Fishers-based pajama company wins $50,000 prize on new Bloomberg TV competition
-
In midst of pandemic, drugmakers raise prices on hundreds of prescription drugs
Blog Roll
Local senior-living complex more than doubles assisted-living units in $5M expansion
The expansion will consist of 32 new one-bedroom apartments and five two-bedroom residences, bringing to 67 the number of assisted-living apartments at the complex.
Bill would require nursing homes to allow ‘compassionate care’ visits during pandemic
The legislation, Senate Bill 202, would allow designated family members to visit residents under end-of-life and other serious circumstances.
In midst of pandemic, drugmakers raise prices on hundreds of prescription drugs
So far this month, drugmakers have hiked prices on 636 drugs, according to research by GoodRx, which tracks prescription drug prices and offer a mobile app to help consumers find the lowest prices on hundreds of drugs.
How you can keep a close eye on vaccinations in Indiana
The state’s new dashboard on COVID-19 vaccines provides interesting breakdowns on who is getting vaccinated, by county, by gender, by race, by age and a host of other statistics sure to please any proud data geek.
Indiana’s life sciences sector racks up annual record $257M in venture funding
The 39 companies that won venture funding represent a wide range of therapeutics, devices and health information technology.
The shrinking Pfizer vaccine allotment: An Indiana mystery wrapped in a riddle
Last week, state health officials said they expected to initially receive 55,575 doses of Pfizer’s COVID-19 vaccine, and had already begun vaccinating front-line health care workers. But just five days later, state officials and hospitals are keeping mum about how many doses they actually received, except to say it was fewer than expected.
Lilly starting new trial for COVID-19 antibody, potentially widening already red-hot market
Lilly said it will enroll up to 500,000 people in its latest study, with at least 5,000 people expected to receive bamlanivimab therapy. The drugmaker is partnering with health insurer UnitedHealth Group to see if the drug will help high-risk people.
Statewide pandemic numbers hit new heights in November
In every significant statistical category, November has been a record-setter for the COVID-19 pandemic in Indiana, with cases, deaths and hospitalizations far exceeding even the early months of the coronavirus outbreak.
Amid pandemic, Ascension St. Vincent parent shows dramatic swing from red ink to black
Despite the change in fortunes, Ascension signaled that it is not yet out of the woods, noting that “consumer confidence and healthcare hesitation as a result of COVID-19 continue to affect Ascension markets, to varying degrees.”
The check is in the mail from health insurers, but Hoosiers won’t get big payday
Under the Affordable Care Act, health insurers are required to spend 80% to 85% of the revenue they get from premiums on medical care. If they don’t, they have to issue rebates or credits to make up the difference.